Edinburgh Research Explorer

Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis

Research output: Contribution to journalArticle

Standard

Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis. / Scottish Audit of Intracranial Vascular Malformations (SAIVMs) steering committee and collaborators.

In: Lancet Neurology, 01.08.2019.

Research output: Contribution to journalArticle

Harvard

Scottish Audit of Intracranial Vascular Malformations (SAIVMs) steering committee and collaborators 2019, 'Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis', Lancet Neurology. https://doi.org/10.1016/S1474-4422(19)30231-5

APA

Scottish Audit of Intracranial Vascular Malformations (SAIVMs) steering committee and collaborators (2019). Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurology. https://doi.org/10.1016/S1474-4422(19)30231-5

Vancouver

Scottish Audit of Intracranial Vascular Malformations (SAIVMs) steering committee and collaborators. Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurology. 2019 Aug 1. https://doi.org/10.1016/S1474-4422(19)30231-5

Author

Scottish Audit of Intracranial Vascular Malformations (SAIVMs) steering committee and collaborators. / Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis. In: Lancet Neurology. 2019.